Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004–2008) - Neufeld, E J; Kessler, C M; Gill, J C; Wilke, C T; Cooper, D L (Haemophilia, 2011)
; Htrs Investigators.